Rapport Therapeutics, Inc. Common Stock Dividends
The next dividend date for Rapport Therapeutics, Inc. Common Stock has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Rapport Therapeutics, Inc. Common Stock (RAPP)
More About Rapport Therapeutics, Inc. Common Stock
Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders. The company was formerly known as Precision Neuroscience NewCo, Inc. and changed its name to Rapport Therapeutics, Inc. in October 2022. Rapport Therapeutics, Inc. was incorporated in 2022 and is based in Boston, Massachusetts.
Owning Rapport Therapeutics, Inc. Common Stock Stock on the Dividend Date
If you own Rapport Therapeutics, Inc. Common Stock stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Rapport Therapeutics, Inc. Common Stock stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Rapport Therapeutics, Inc. Common Stock stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Rapport Therapeutics, Inc. Common Stock stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Rapport Therapeutics, Inc. Common Stock dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Rapport Therapeutics, Inc. Common Stock Dividends
You can contact us any time if you would like to ask questions about Rapport Therapeutics, Inc. Common Stock dividends or anything else related to the stock market.